Skip to main navigation Skip to search Skip to main content

Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade

  • Samuel Rosner
  • , Sydney Connor
  • , Khaled Sanber
  • , Marianna Zahurak
  • , Tianbei Zhang
  • , Isha Gurumurthy
  • , Zhen Zeng
  • , Brad Presson
  • , Dipika Singh
  • , Roni Rayes
  • , Lavanya Sivapalan
  • , Gavin Pereira
  • , Zhicheng Ji
  • , Rohit Thummalapalli
  • , Joshua E. Reuss
  • , Stephen R. Broderick
  • , David R. Jones
  • , Julie S. Deutsch
  • , Tricia R. Cottrell
  • , Jamie E. Chaft
    • Jonathan Spicer, Janis Taube, Valsamo Anagnostou, Julie R. Brahmer, Drew M. Pardoll, Hongkai Ji, Patrick M. Forde, Kristen A. Marrone, Kellie N. Smith

Research output: Contribution to journal › Article › peer-review

12   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry